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Aim: We estimated numbers of persons, born between 1950
and 1985 in Japan, who were persistently infected with hepa-
titis B virus (HBV) through vertical and horizontal infections.
Methods: HBV carrier rates with vertical and horizontal
infections were computed using sex- and age-speciﬁc
prevalence rates of hepatitis B surface antigen (HBsAg) and
hepatitis B e-antigen (HBeAg) by mathematical model. Prob-
abilities of vertical HBV transmission in babies born to carrier
mothers with and without HBeAg were presumed to be 90%
and 10%, respectively.
Results: HBV carrier rates with vertical infection stayed con-
trast at approximately 0.3% in birth cohorts through 36 years
(1950–1985), both in men and women. By a remarkable con-
stant, HBV carrier rates with horizontal infection decreased
steadily from 1.43% to 0.10% in men and from 0.95% to 0.03%
in women. The estimated total number of HBV carriers born
between 1950 and 1985 was 522 500 (355 488–693 606). Of
them, the numbers of HBV carriers with vertical and horizon-
tal infections were 197 574 (149 505–288 709) and 324 926
(205 983–404 896); they accounted for 37.81% and 62.19%,
respectively, with a ratio of 1:1.64. The ratio between vertical
and horizontal infections was 1:2.20 in men and 1:1.06 in
women.
Conclusion: Vertical HBV infection had stayed constant until
immunoprophylaxis of mother-to-baby transmission was
implemented in 1986 in Japan. In contrast, horizontal HBV
infection decreased over years. The decrease would be due to
many factors, including improved socioeconomic environ-
ments, advanced medical maneuvers and equipment, and
careful vaccination procedures.
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INTRODUCTION
THERE ARE AN estimated 350 million peopleinfected persistently with hepatitis B virus (HBV) in
the world.1 Of them, the majority (75%) are living in
Asia, and approximately 25% die of serious long-term
complications of HBV infections, such as decompen-
sated cirrhosis and hepatocellular carcinoma (HCC).2
Persistent HBV infection is mainly established by verti-
cal transmission from carrier mothers or horizontal
transmission during their infancy. It is clinically and
epidemiologically relevant to examine numbers of HBV
carriers with vertical and horizontal transmissions, and
the ratio between them, because different strategies are
required to prevent each of them.
Hepatitis B e-antigen (HBeAg) in the serum of carrier
mothers is a useful marker for a high possibility of
vertical transmission. Persistent HBV infection is estab-
lished in 90% of babies born to carrier mothers with
HBeAg,3–6 while only in 10% of babies born to those
without HBeAg.7 Thus, it is possible to estimate the
number of vertical HBV infection in babies born to a
given cohort of mothers in whom prevalence rates of
hepatitis B surface antigen (HBsAg) and HBeAg are
known.
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Vertical HBV transmission can be prevented by
passive and active immunoprophylaxis of babies born
to carrier mothers with hepatitis B immunoglobulin and
vaccine. Since 1986, the national immunoprophylaxis
program was implemented in babies born to HBeAg
positive carrier mothers in Japan. It is efficient in pre-
venting mother-to-baby transmission, except in babies
who have been infected with HBV in utero.8
In this study, numbers of vertical and horizontal HBV
infection were estimated for men and women who were
born during the 36 years between 1950 and 1985,
before immunoprophylaxis was started in Japan.
METHODS
Study cohorts
FROM THE VITAL Statistics of Japan,9 the followingdata were obtained for the Japanese born during
1950–1985: (i) the number of births by sex; (ii) the
number of deliveries by mothers in 5-year age groups;
(iii) sex ratio of newborns; and (iv) the mortality rate.
From the census in Japan, the number of subpopulation
stratified by sex and age at 2005 was obtained.10
HBV markers in study cohorts
Hepatitis B surface antigen positive rates stratified by sex
and birth year were obtained for the first-time blood
donors during 1995–2000 in Japan,11 and from the fact
sheet on HBV by the National Institute of Infectious
Diseases.7 HBeAg positive rates among HBsAg positive
women grouped by 10 years were reported by Sasaki
et al.12 The study design conformed to the 1975 Decla-
ration of Helsinki.
Assumptions
We assumed that age-specific HBV carrier rates in
mothers who were born before 1930 to be the same as
those in the birth group from 1931 to 1935, which is the
oldest birth group among studied subjects.11 The possi-
bility of HBV transmission to her baby was assumed to
be 90% for a carrier mother with HBeAg, and 10% for a
carrier mother without HBeAg.7
Estimation
Estimation of the numbers of HBV carriers with
vertical infection in birth groups notched by 1 year
from 1950 to 1985
1 The number of babies born to HBV carrier mothers in
1-year notched birth year j (j = 1950, 51, 52, . . . ,
85:36 points) was estimated by the equation: Σi
(Nji * Sji): numbers of births to mothers in the age
group “i”, Nji (i = 1 for 15–19 years old [y.o.], i = 2
for 20–24 y.o., . . . , i = 7 for 45–49 y.o.) (Fig. 1) and
HBV carrier rate in the corresponding age group of
mothers, Sji (i = 1 for birth in [j − 19] − [j − 15], i = 2
for birth in [j − 24] − [j − 20], . . . , i = 7 for birth in
[j − 49] − [j − 45]).
2 The numbers of babies whose mothers were positive
and negative for HBeAg were estimated using a group-
specific HBeAg positive rate Ei (Fig. 1), and HBeAg
negative rate, 1 − Ei, by the respective equations:
ΣiNji * Sji * Ei and ΣiNji * Sji * (1 − Ei).
3 The number of HBV carrier babies with vertical
infection (CVj) was estimated by the formula:
CVj = 0.1 * ΣiNji * Sji * (1 − Ei) + 0.9 * ΣiNji * Sji *Ei.
4 Using the sex ratio (Gj), the numbers of HBV
carriers with vertical infection (CVMj) for men and
(CVFj) for women were calculated in birth groups
notched by 1 year, by the respective equations:
CVMj = Gj / (1 + Gj) * CVj and CVFj = 1 / (1 + Gj) *
CVj.
5 Finally, rates of HBV carriers with vertical infection
in men (BSMVj) and women (BSFVj), respectively, to
total number of birth in men (NMj) and women (NFj)
were estimated in birth groups notched by 1 year
by respective equations: (BSMVj) = CVMj / NMj and
(BSFVj) = CVFj / NFj with 95% confidence interval
(CI).
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Figure 1 Number of births from mothers in 5-year age groups
shifting during 1950–1985. Each component in bar graphs
indicates number of live births stratified by the age of mother
(15–19, 20–24, . . . , 45–49 years old). Age-specific hepatitis B
e-antigen positive rates among hepatitis B virus carrier women
are shown on the right.
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Estimation of the number of HBV carriers with
horizontal infection in birth groups notched by
1 year from 1950 to 1985
At first, number of HBV carriers was calculated by mul-
tiplying the number of births (NMj and NFj) by the HBV
carrier rate in men and women in 1-year notched birth
year j (33 points; 1950–1982), which were calculated by
the 5-year moving average method, and that in birth
year j (3 points; 1983–1985) was assumed as the same
as that in the birth year cohort of 1982. The number of
HBV carriers with horizontal infection (CHMj and CHFj)
was calculated by subtracting the estimated number of
HBV carriers with vertical infection (CVMj and CVFj) from
the estimated total number of HBV carriers.
Estimation of the number of HBV carriers taking
into account the mortality rate at 2005
Multiplying the numbers of HBV carriers in 1-year
notched birth groups by the corresponding sex- and
age-specific survival rates at 2005, the numbers of HBV
carriers presumed to be alive at 2005 were obtained.
They were summed to estimate the total numbers of
HBV carriers.
Statistical analysis
We constructed 95% CI for the rate of HBV carriers with
vertical infection using 95% CI for production of two
positive rates (see Appendix for details). The χ2-test was
used for comparison of HBV carrier rates with vertical
and horizontal infections. A P-value less than 0.05 was
considered to indicate statistical significance.
RESULTS
HBV carrier rates and proportions of
vertical and horizontal transmissions
during 1950–1985
FIGURE 2 ILLUSTRATES HBV carrier rates in men andwomen born between 1950 and 1985 in Japan. HBV
carrier rates decreased gradually both in men and
women during these years, from 1.75% to 0.30% and
from 1.27% to 0.23%, respectively.
Contribution of vertical or horizontal infection to
carrier rates was estimated by a mathematical model
described in Methods. The rate of HBV carriers with
vertical infection stayed constant at approximately
0.3% in birth cohorts between 1950 and 1980, and
decreased to 0.20% in the birth cohort of 1985. By a
remarkable contrast, the rate of HBV carriers with hori-
zontal infection decreased gradually between 1950 and
1985 both in men and women, from 1.43% to 0.10%
and from 0.95% to 0.03%, respectively. The extent of
decrease, in the rate of HBV carriers with horizontal
infection, was higher for men than women (1.33% vs
0.92%, P < 0.001). The difference in HBV carrier rate
with horizontal infection between men and women
was statistically significant in groups born before 1972
(P < 0.05).
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Figure 2 Hepatitis B virus (HBV) carrier rates and proportions of vertical and horizontal transmissions in yearly birth groups
during 1950–1985. HBV carrier rates of vertical and horizontal transmissions are shown. Bars indicate the 95% confidence interval
of vertical transmission rate. (a) Men, (b) women. , horizontal transmission; , vertical transmission.
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Estimation of the numbers of HBV carriers
with vertical and horizontal infections in
birth groups notched by 1 year between
1950 and 1985
Estimated numbers of HBV carriers with vertical and
horizontal transmissions in 1-year notched birth
cohorts during the 36 years between 1950 and 1985 are
illustrated in Figure 3, both for men and women. The
results are summarized in Table 1.
The estimated total number of HBV carriers born
between 1950 and 1985 was 522 500. Of them, the
estimated number of HBV carriers with vertical infection
was 197 574, and those with horizontal infection was
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Figure 3 Estimated numbers of hepatitis B virus (HBV) carriers with vertical or horizontal transmission who were born during the
36 years between 1950 and 1985 and alive in 2005 in yearly birth groups. The ratio of the number of HBV carriers between vertical
and horizontal transmissions are shown below for indicated time periods. (a) Men, (b) women, (c) men in 2005, (d) women in
2005. , horizontal transmission; , vertical transmission.
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324 926; they accounted for 37.81% and 62.19% of
total carriers, respectively, with a ratio of 1:1.64. Of
324 945 HBV carrier men, 101 673 had vertical infec-
tion and 223 273 had horizontal infection, accounting
for 31.29% and 68.71%, respectively, with a ratio of
1:2.20.
Likewise, of 197 555 HBV carrier women, 95 901 had
vertical infection and 101 654 had horizontal infection;
they accounted for 48.54% and 51.46%, respectively,
with a ratio of 1:1.06.
Moreover, the ratio between the number of HBV car-
riers with vertical infection and those with horizontal
infection increased remarkably in men from 1:3.93 in
the birth cohort during 1950–1959 to 1:2.32 during
1960–1969 and to 1:1.09 during 1970–1979, and
reached the highest at 1:0.37 during 1980–1985. Simi-
larly, in women, the ratio between the number of
HBV carriers with vertical infection and those with
horizontal infection increased steadily with 1:2.17,
1:0.83, 1:0.56 and 1:0.06 in birth cohorts during 1950–
1959, 1960–1969, 1970–1979 and 1980–1985, respec-
tively. However, during 1950–1985, while the number
of HBV carriers with vertical infection decreased slightly,
the number of HBV carriers with horizontal infection
declined remarkably, both for men and women.
In women, the number of horizontal transmissions
increased slightly during 1963–1973. This was,
however, not the case for men in whom horizontal
transmission decreased steadily through the study
period (1950–1985).
Estimation of the number of HBV carriers
taking into account the mortality rate
at 2005
The number of live HBV carriers of a given birth year was
calculated, taking into account the corresponding mor-
tality rate at 2005 for the birth groups of 1950–1985
(Fig. 3). The estimated number of HBV carriers born
between 1950 and 1985 and alive in 2005 is 486 038,
corresponding to 93.02% of the 522 500 carriers who
were born during the 36 years. Of them, the estimated
number of HBV carriers with vertical infection is
185 871 (38.24%) and those with horizontal infection
is 300 168 (61.76%), with a ratio of 1:1.61 (Table 1). Of
297 031 HBV carrier men, 93 773 (31.57%) had vertical
transmission, and 203 258 (68.43%) had horizontal
infection, with a ratio of 1:2.17. Likewise, of 189 007
HBV carrier women, 92 098 (48.73%) had vertical infec-
tion, and 96 909 (51.27%) had horizontal infection,
with a ratio of 1:1.05.
In addition, the ratio between the number of HBV
carriers alive in 2005 with vertical infection and those
with horizontal infection in men also increased consid-
erably from 1:3.92 in the birth cohort during 1950–1959
to 1:2.32 in 1960–1969, then to 1:1.09 in 1970–1979
and peaked at 1:0.37 in 1980–1985. Likewise for
women, in birth cohorts during 1950–1959, 1960–
1969, 1970–1979 and 1980–1985, the ratio between the
number of HBV carriers alive in 2005 with vertical infec-
tion and those with horizontal infection was 1:2.16,
1:0.83, 1:0.56 and 1:0.06, respectively, showing an
increasing trend between 1950 and 1985. As a whole,
through the 36-year period, the number of HBV carriers
alive in 2005 with horizontal infection decreased to an
extent higher than those with vertical infection.
Thus, 93.02% of HBV carriers born during 1950–
1985 would be alive in 2005. In the total of 486 038
carriers living in 2005, there were 297 031 (61.11%)
men and 189 007 (38.89%) women with a ratio of
1.57:1 (Table 1). Overall, horizontal transmission was
approximately sesquialteral as frequent as vertical trans-
mission among HBV carriers. Proportion of horizontal
Table 1 Estimated numbers of hepatitis B virus carriers with vertical or horizontal transmission who were born during the 36 years
between 1950 and 1985 and alive in 2005
Estimated number of HBV carriers (95% confidence interval)
Total With vertical transmission With horizontal transmission
Whole
Total 522 500 (355 488–693 606) 197 574 (149 505–288 709) 324 926 (205 983–404 896)
Men 324 945 (235 765–414 592) 101 673 (76 948–148 542) 223 273 (158 817–266 047)
Women 197 555 (119 723–279 014) 95 901 (72 557–140 167) 101 654 (47 166–138 847)
In 2005
Total 486 038 (329 981–646 011) 185 871 (140 826–271 096) 300 168 (189 155–374 914)
Men 297 031 (215 484–379 016) 93 773 (71 094–136 631) 203 258 (144 390–242 385)
Women 189 007 (114 497–266 995) 92 098 (69 732–134 465) 96 909 (44 765–132 529)
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transmission was higher in men than women who
carried HBV (68.43% vs 51.27% [1.33:1], P < 0.001).
DISCUSSION
PERSISTENT HBV INFECTION in a given communityhad been maintained by two principal routes. One
of them is the vertical infection from mothers who carry
HBV to their babies, and the other is the horizontal
infection, typically during an early childhood.13–15 The
contribution of vertical or horizontal transmission to
establish HBV carrier state is subject to host and viral
factors, and varies among different countries. In Asian
countries where HBV is endemic, with the prevalence of
HBsAg of 8% or higher,16 the vertical infection had been
the main route of transmission for establishing HBV
carrier state.
In 1980, plasma-derived hepatitis B (HB) vaccine was
produced and introduced to babies born to mothers
infected with HBV. As the HB vaccine was very efficient
in preventing vertical infection,17 the World Health
Organization recommended universal vaccination of all
babies, regardless of the mother’s infection with HBV.
By the end of 2011, the HB vaccine was introduced to
179 (93%) of the 193 member states; 93 (52%) recom-
mended the first dose within 24 h of birth to prevent
vertical transmission of HBV.18 Hence, the contribution
of vertical transmission to establish persistent HBV
infection, in comparison with that of horizontal trans-
mission, has to be examined in persons born before the
implementation of HB vaccine to prophylaxis of vertical
transmission.
Japan is a country of low endemicity for HBV, with the
prevalence of HBsAg of less than 2% at the same level as
those in Australia and New Zealand, although they
belong to Asia.16 Because the vertical infection was
regarded as the principal route for establishing persis-
tent HBV carrier state, a national program for passive
and active immunoprophylaxis of babies born to carrier
mothers was launched in 1986.8 Initially, only the
babies born to carrier mothers with HBeAg were indi-
cated to immunoprophylaxis, in view of a high efficacy
(∼90%) of transmitting persistent HBV infection to their
babies.3–7,19 Since 1995, the indication was expanded to
include babies born to carrier mothers without HBeAg.
In this study, we estimated the contribution of vertical
and horizontal transmissions to the HBV carrier state
in Japan. To avoid the effect of immunoprophylaxis,
persons born during the 36 years between 1950 and
1985, before the start of immunoprophylaxis in 1986,
were examined. A mathematical model was devised to
estimate the number of HBV carriers with vertical infec-
tion. It involved HBsAg positive rates stratified by sex
and birth year examined in the first-time blood donors
during 1995–2000 in Japan,11 and retrieved from the
fact sheet on HBV by the National Institute of Infectious
Diseases.7 HBeAg positive rates among HBsAg positive
women in 10-year age groups were reported by Sasaki
et al.12 The efficacy of vertical infection was assumed to
be 90% for carrier mothers with HBeAg and 10% for
those without HBeAg.7 Then, the number of HBV carri-
ers with horizontal infection was obtained by subtract-
ing the number of HBV carriers with vertical infection
from the total number of HBV carriers.
There were remarkable differences between the con-
tribution of vertical and horizontal infections to the
HBV carrier rate in birth cohorts during 1950–1985
(Fig. 2). The rate of HBV carriers with vertical infection
stayed constant at 0.3% through the 36 years. By con-
trast, the rate of carriers with horizontal infection kept
decreasing through these years, from 1.43% to 0.10% in
men, and from 0.95% to 0.03% in women.
Numbers of HBV carriers with vertical and horizontal
infections were obtained for persons born during 1950–
1985 (Table 1). However, they would not represent
numbers of HBV carriers in recent years, because some
of them would have been deceased. Hence, numbers of
HBV carriers with vertical and horizontal infections were
obtained for persons who would be alive in 2005, the
year when sex- and age-specific prevalence rates of
HBsAg were determined in the first-time blood donors.20
The estimated number of HBV carriers who were born
between 1950 and 1985 and alive in 2005 is 486 038,
corresponding to 93.02% of the 522 500 carriers who
were born during the 36 years. Of them, the estimated
number of HBV carriers with vertical infection is
185 871 and those with horizontal infection is 300 168,
accounting for 38.24% and 61.76%, respectively, with a
ratio of 1:1.61. Proportion of horizontal infection was
greater for men than women who carried HBV (68.43%
vs 51.27%, P < 0.001). The higher proportion of hori-
zontal infection in men than women would be due to
increased chances of body contacts during physical
activities in boys than girls, resulting in the break of skin
and contamination with HBsAg positive blood. In addi-
tion, immune responses to protect from persistent HBV
infection might have been lower in boys than girls.
It is of a particular note that the HBV carrier rate had
already decreased during 1950–1985 in Japan, before
the immunoprophylaxis program was started in 1986.
The decrease was due to reduction of horizontal HBV
infection (Fig. 2). The diminution of horizontal HBV
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infection would be due to many factors, including
improved socioeconomic environments, improved
awareness of risks for infection, such as sharing a tooth-
brush and shaver, and advanced medical maneuvers and
equipment, as well as careful vaccination procedures.
Disposable needles and syringes, introduced in the early
1960s and universally distributed in the late 1970s in
Japan, would have given the highest impact on decreas-
ing horizontal transmission to establish the HBV carrier
state.
It may be worth mentioning that, in women, the
number of horizontal transmission increased slightly
during 1963–1973 (Fig. 3). This was, however, not
the case for men in whom horizontal transmission
decreased steadily through the study period (1950–
1985). It is not certain why horizontal infection of HBV
increased preferentially in women during 1963–1973.
However, vertical infection increased in women also
during this period. Therefore, when the ratio of vertical
to horizontal transmission was compared during four
timespans of approximately 10 years in the entire study
period (Fig. 3), the ratio kept increasing throughout
1950–1985 in women (from 1:2.16 to 1:0.06), as in
men (1:3.92 to 1:0.37).
It has to be pointed out that this study has limitations.
The HBV carrier rate of pregnant mothers may have been
underestimated, because HBsAg positive rates in the
first-time blood donors surveyed during 1995–2000
were used to estimate it.11 Hence, the number of HBV
carriers with vertical infection might have been under-
estimated. Moreover, the loss of HBsAg in the natural
course, which is reported in recent years,21 might have
influenced the estimation in this study toward underes-
timation of HBV carriers.22,23 However, such a large-scale
survey in the 1990s with the standardized HBsAg screen-
ing level throughout the entirety of Japan had not
existed except in the first-time blood donors, the data-
base used for this mathematical model. In addition in
the 1990s, the questionnaires to donors before their
donation had not been strict enough to exclude the
high-risk group of HBV and HCV infections than in the
2000s. Therefore, it may be worthwhile to estimate
the proportion of the number of HBV carriers with ver-
tical and horizontal infections in the first-time blood
donors nowadays.
These constraints notwithstanding, contribution of
horizontal infection to establish HBV carrier state, in
comparison with that of vertical infection, decreased
remarkably over years in Japan, even before the
immunoprophylaxis of babies born to HBV carrier
mothers was implemented in 1986. Furthermore, the
prevalence of HBsAg in children decreased sharply from
0.75% (78/10 437) in the children born during 1978–
1980 to 0.04% (12/32 049) in those during 1986–
1990.24 It is to be hoped that yearly trends of horizontal
and vertical transmissions to establish HBV carrier states
during the post-World War II era, described herein, may
help in decision-making in Japan, whether to keep
resorting solely to selective vaccination, or step toward
mass vaccination of babies and/or teenagers. Increasing
horizontal transmission for the persistent HBV carrier
state transmitted by sexual contacts, typically with a
foreign subgenotype A2,25–29 must be taken into consid-
erations in making such decisions. For this purpose, it is
imperative to estimate the number of horizontal infec-
tion with genotype A, which is expected to have accu-
mulated rapidly, by extensive epidemiological surveys
in Japan.
ACKNOWLEDGMENT
THIS WORK WAS supported by a Grant-in-Aid fromMinistry of Health, Labour and Welfare in Japan
(Research on Hepatitis).
REFERENCES
1 World Health Organization. Viral hepatitis: report by the
Secretariat. Sixty-Second World Health Assembly 2009.
Available at: http://apps.who.int/gb/ebwha/pdf_files/A62/
A62_22-en.pdf. Accessed October 6, 2013.
2 CDC. Recommendations for identification and public
health management of persons with chronic hepatitis B
virus infection. MMWR Morb Mortal Wkly Rep 2008; 57:
1–20. Available at: http://www.cdc.gov/mmwr/preview/
mmwrhtml/rr5708a1.htm. Accessed October 6, 2013.
3 Beasley RP, Trepo C, Stevens CE, Szmuness W. The e
antigen and vertical transmission of hepatitis B surface
antigen. Am J Epidemiol 1977; 105: 94–8.
4 Shiraki K. Perinatal transmission of hepatitis B virus and
its prevention. J Gastroenterol Hepatol 2000; 15 (Suppl):
E11–5.
5 Okada K, Kamiyama I, Inomata M, Imai M, Miyakawa Y,
Mayumi M. E antigen and anti-e in the serum of asymp-
tomatic carrier mothers as indicators of positive and nega-
tive transmission of hepatitis B virus to their infants. N Engl
J Med 1976; 294: 746–9.
6 Shiraki K, Yoshihara N, Sakurai M, Eto T, Kawana T. Acute
hepatitis B in infants born to carrier mother with the anti-
body to hepatitis B e antigen. J Pediatr 1980; 97: 768–70.
7 National institute of infectious diseases. Factsheet on hepa-
titis B virus vaccination (in Japanese). 2010. Available
at: http://www.mhlw.go.jp/stf/shingi/2r9852000000bx23
-att/2r9852000000bxqf.pdf. Accessed October 6, 2013.
Hepatology Research 2014; 44: E181–E188 Vertical and horizontal HBV infections in Japan E187
© 2013 The Japan Society of Hepatology
8 Eto T, Shiraki K. National project on the prevention of
mother-to-infant infection by hepatitis B virus in Japan.
Acta Paediatr Jpn 1989; 31: 681–4.
9 Ministry of Health Labour and Welfare. Vital Statistics of
Japan. Tokyo: Health, Labour and Welfare Statistics Asso-
ciation, 1950–85.
10 Statistics Bureau, Ministry of Internal Affairs and Commu-
nications. 2005 Population Census of Japan. Tokyo: Statistics
Bureau Ministry of Internal Affairs and Communications,
2007.
11 Tanaka J, Kumagai J, Katayama K et al. Sex- and age-specific
carriers of hepatitis B and C viruses in Japan estimated by
the prevalence in the 3,485,648 first-time blood donors
during 1995–2000. Intervirology 2004; 47: 32–40.
12 Sasaki T, Hattori T, Mayumi M. A large-scale survey on the
prevalence of HBeAg and anti-HBe among asymptomatic
carriers of HBV. Correlation with sex, age, HBsAg titre and
s-GPT value. Vox Sang 1979; 37: 216–21.
13 Chang MH. Chronic hepatitis virus infection in children.
J Gastroenterol Hepatol 1998; 13: 541–8.
14 Hsu HY, Chang MH, Chen DS, Lee CY, Sung JL. Baseline
seroepidemiology of hepatitis B virus infection in children
in Taipei, 1984: a study just before mass hepatitis B vacci-
nation program in Taiwan. J Med Virol 1986; 18: 301–7.
15 Stevens CE, Beasley RP, Tsui J, Lee WC. Vertical transmis-
sion of hepatitis B antigen in Taiwan. N Engl J Med 1975;
292: 771–4.
16 Rani M, Yang B, Nesbit R. Hepatitis B control by 2012 in
the WHO Western Pacific Region: rationale and implica-
tions. Bull World Health Organ 2009; 87: 707–13.
17 Nair PV, Weissman JY, Tong MJ, Thursby MW, Paul RH,
Henneman CE. Efficacy of hepatitis B immune globulin in
prevention of perinatal transmission of the hepatitis B
virus. Gastroenterology 1984; 87: 293–8.
18 World Health Organization. Hepatitis B. 2013. Available
at: http://www.who.int/mediacentre/factsheets/fs204/en/.
Accessed October 6, 2013.
19 Shiraki K, Nagata I, Iizuka T, Kaji S. Mother-to-infant infec-
tion by hepatitis B virus and its prevention in Japan. Int
Hepatol Commun 1996; 5: 74–8.
20 Tanaka J, Koyama T, Mizui M et al. Total numbers of undi-
agnosed carriers of hepatitis C and B viruses in Japan esti-
mated by age- and area-specific prevalence on the national
scale. Intervirology 2011; 54: 185–95.
21 Kobayashi M, Hosaka T, Suzuki F et al. Seroclearance rate
of hepatitis B surface antigen in 2,112 patients with
chronic hepatitis in Japan during long-term follow-up.
J Gastroenterol 2013; [Epub ahead of print].
22 Kato Y, Nakao K, Hamasaki K et al. Spontaneous loss
of hepatitis B surface antigen in chronic carriers, based
on a long-term follow-up study in Goto Islands, Japan.
J Gastroenterol 2000; 35: 201–5.
23 Chu CM, Liaw YF. HBsAg seroclearance in asymptomatic
carriers of high endemic areas: appreciably high rates
during a long-term follow-up. Hepatology 2007; 45: 1187–
92.
24 Koyama T, Mito H, Takahashi K, Tanaka J, Mushahwar IK,
Yoshizawa H. Perinatal hepatitis B virus infection in Japan.
In: Mushahwar IK, ed. Congenital and Other Related Infec-
tious Diseases of the Newborn. Oxford: Elsevier Science &
Technology Books, 2006; 141–51.
25 Tamada Y, Yatsuhashi H, Masaki N et al. Hepatitis B
virus strains of subgenotype A2 with an identical sequence
spreading rapidly from the capital region to all over
Japan in patients with acute hepatitis B. Gut 2012; 61:
765–73.
26 Sugauchi F, Orito E, Ohno T et al. Spatial and chronologi-
cal differences in hepatitis B virus genotypes from patients
with acute hepatitis B in Japan. Hepatol Res 2006; 36: 107–
14.
27 Ozasa A, Tanaka Y, Orito E et al. Influence of genotypes
and precore mutations on fulminant or chronic outcome
of acute hepatitis B virus infection. Hepatology 2006; 44:
326–34.
28 Kobayashi M, Ikeda K, Arase Y et al. Change of hepatitis B
virus genotypes in acute and chronic infections in Japan.
J Med Virol 2008; 80: 1880–4.
29 Uchida Y, Kouyama JI, Naiki K et al. A novel HBV strain
developing due to recombination between genotypes H
and B strains isolated from a Japanese patient. Hepatol Res
2013; [Epub ahead of print].
APPENDIX
WE CONSTRUCTED 95% confidence intervals(CI) for the rate of hepatitis B virus (HBV) carriers
with vertical infection using 95% CI for production of
two positive rates. In the Appendix, we show the con-
duction of 95% CI for production of two positive rates.
Let n1 and n2 be numbers of two independent groups,
x1 and x2 be numbers of positive in each group, and
p1 = x1 / n1, p2 = x2 / n2 be positive rates in each group.
Then, the 95% CI of log p1 and log p2 are asymptoti-
cally normal distributed with asymptotic variance
(1 − p1) / n1p1 and (1 − p2) / n2p2. Thus, 95% CI for
product of two positive rates is given by
p p p n p p n p1 2 1 1 1 2 2 21 96 1 1exp .± −( ) + −( )( ).
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